Loading...

Bonus BioGroup Ltd.

BBIXF•PNK
HealthcareBiotechnology
$0.05
$0.05(50900.002%)

Bonus BioGroup Ltd. (BBIXF) Stock Overview

Explore Bonus BioGroup Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for BBIXFStats details for BBIXF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for BBIXFAnalyst Recommendations details for BBIXF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. It develops tissue-regenerating bone grafts from cells derived from the patient's own cells for the treatment of skeletal disorders, such as bone trauma and arthritis. The company's products include BonoFill injectable bone graft that is suitable for bone repair applications, including jaw bone cysts; and BonoFill pre-designed bone graft, which is used to repair large and segmental bone defects. Its products in pipeline comprise bone grafts for maxillofacial and orthopedic applications; novel nanomaterials technology for tissue regeneration; and large vascularized bone grafts. The company was formerly known as Oceana Advanced Industries Ltd. and changed its name to Bonus BioGroup Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.

CEO

Dr. Shai Meretzki Ph.D.

Employees

49

Headquarters

Matam Advanced Technology Park, Haifa

Founded

2019

Frequently Asked Questions